Skip to main content
BIOXYNE LIMITED logo

BIOXYNE LIMITED — Investor Relations & Filings

Ticker · BXN ISIN · AU000000BXN6 LEI · 984500F02D2B1B94E956 ASX Manufacturing
Open in API
Filings indexed 842 across all filing types
Latest filing 2023-07-30 Interim / Quarterly Rep…
Country AU Australia
Listing ASX BXN

About BIOXYNE LIMITED

https://bioxyne.com

Bioxyne Limited is a life sciences company focused on the development, manufacture, and commercialization of health and wellness products. The company specializes in proprietary probiotic strains, notably the Lactobacillus fermentum VRI-003 (PCC), which is utilized in supplements targeting immune health and gut function. Following the acquisition of Breathe Life Sciences, Bioxyne has expanded its portfolio into the medicinal cannabis sector, novel foods, and consumer health products. Its operations encompass the production and distribution of pharmaceutical-grade cannabis products, CBD-based wellness items, and functional supplements. The company serves international markets through a vertically integrated model, focusing on research-driven formulations and high-quality manufacturing standards to address growing consumer demand for therapeutic and preventative health solutions.

Recent filings

Filing Released Lang Actions
Quarterly Activities/Appendix 4C Cash Flow Report 9 pages 954.3KB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated 31 July 2023 reporting on the quarter ended 30 June 2023. It includes detailed financial and operational highlights, including revenue figures, acquisition details, director appointments, and an Appendix 4C quarterly cash flow report as required by ASX Listing Rule 4.7B. The presence of actual financial data for the quarter, including cash flow statements and operational results, indicates this is a comprehensive quarterly report rather than a brief announcement or certification. The document is not a full annual report (10-K), nor is it a simple earnings release (ER) since it contains detailed financial statements and operational commentary. It is not a call transcript, audit report, or other categories. Therefore, the document fits the definition of an Interim / Quarterly Report (IR). Q4 2023
2023-07-30 English
BLS Extends Amazon Footprint into US and Japan 2 pages 658.5KB
Regulatory Filings Classification · 95% confidence The document is a company announcement dated 17 July 2023, released to the Australian Securities Exchange (ASX). It discusses the extension of Breathe Life Sciences' product sales on Amazon in the US and Japan, highlights business activities, and provides background on the company and its subsidiaries. The content focuses on business updates, product launches, and market expansion forecasts rather than detailed financial results or comprehensive financial statements. There is no indication of quarterly or annual financial reporting, audit information, or regulatory certifications. The document is a typical corporate announcement about business developments and market activities, which fits best under the category of Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2023-07-16 English
Bioxyne Launches BLS Clinics - Online Healthcare 2 pages 654.8KB
Regulatory Filings Classification · 95% confidence The document is a company announcement from Breathe Life Sciences (BLS) regarding the launch of a new online healthcare business, BLS Clinics. It includes details about the business model, partnerships, licenses, and product offerings. There are no financial statements, quarterly or annual results, nor any regulatory filings or voting results. The content is an operational update and business launch announcement rather than a financial report, management change, or legal proceeding. It does not fit into categories like Annual Report, Interim Report, Earnings Release, or Capital Update. It is a general company announcement about a new business initiative, which aligns best with Regulatory Filings (RNS) as a fallback category for miscellaneous announcements that do not fit other specific categories.
2023-06-12 English
Becoming a substantial holder 2 pages 208.3KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 filed under the Corporations Act 2001, titled 'Notice of initial substantial holder.' It details the substantial shareholding of GLOBAL CR HOLDINGS LIMITED in BIOXYNE LIMITED, including voting power, relevant interests, and acquisition details. This type of filing is a notification of a major shareholding event, specifically the initial substantial holder notice. It is not a financial report, management announcement, or other types of filings. According to the filing definitions, notifications of changes in significant share ownership levels (crossing thresholds) fall under 'Major Shareholding Notification' (Code: MRQ). The document length and content confirm it is a substantive notification rather than a brief announcement or certification. Therefore, the correct classification is MRQ with high confidence.
2023-06-07 English
Change in substantial holding 3 pages 471.5KB
Major Shareholding Notification Classification · 100% confidence The document is a Form 604 Notice of change of interests of substantial holder under the Corporations Act 2001. It details changes in voting power and relevant interests of a substantial shareholder in the company BIOXYNE LIMITED. The form includes dates of changes, nature of changes, and voting power percentages. This type of filing is a notification of changes in significant share ownership levels, which corresponds to the category Major Shareholding Notification (MRQ). The document is not an annual report, earnings release, or any other financial report but a regulatory notice about shareholding changes.
2023-05-30 English
Becoming a substantial holder 3 pages 1.3MB
Major Shareholding Notification Classification · 100% confidence The document is a Form 603 Notice of Initial Substantial Holder filed under the Corporations Act 2001. It details the acquisition of a substantial shareholding in BIOXYNE LIMITED by Ian Edward Owles, including voting power percentages, nature of relevant interests, registered holders, and consideration paid. This type of filing is a notification of a major shareholding change, specifically the initial substantial holder notice. It is not a financial report, management announcement, or other types of filings such as earnings releases or board changes. Therefore, it fits the category of Major Shareholding Notification (MRQ). The document length and content confirm it is the actual notification, not just an announcement or reference to another report.
2023-05-30 English

Browse filings by year

25 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.